Lipocine Inc. held its annual general meeting of shareholders on June 4, 2025. During the meeting, shareholders approved the amendment to reduce the number of authorized shares of Common Stock from 200,000,000 to 75,000,000. The election of six directors was confirmed. The appointment of Tanner LLC as the independent registered public accountants for the fiscal year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-013603), on June 04, 2025, and is solely responsible for the information contained therein.